Clearside Biomedical Inc (CLSD) — Cash Flow Quality Index

Latest as of December 2021: 0.27x

Clearside Biomedical Inc (CLSD) has a Cash Flow Quality Index of 0.27x as of December 2021. Operating cash flow of $5.05 Million is below net income of $18.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Clearside Biomedical Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.27x
Operating CF / Net Income

Operating Cash Flow

$5.05 Million
USD

Net Income

$18.71 Million
USD

Data as of

Dec 2021
Most recent filing

Clearside Biomedical Inc Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Clearside Biomedical Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CLSD cash flow metrics.

Annual Cash Flow Quality Index for Clearside Biomedical Inc (2021–2021)

Year-by-year earnings quality comparison for Clearside Biomedical Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -28.55x $-10.73 Million $376.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.